Evidence map›Paper›PMID 30126209›Full record

ArticleInternational journal of environmental research and public health2018

Aluminium in Brain Tissue in Multiple Sclerosis.

Matthew Mold, Agata Chmielecka, Maria Raquel Ramirez Rodriguez, Femia Thom, Caroline Linhart, Andrew King, Christopher Exley

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Zeolite and Neurodegenerative Diseases.Molecules (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Aluminium in Brain Tissue in Epilepsy: A Case Report from Camelford.International journal of environmental research and public health · 2019
    Article
  12. Article
  13. Intracellular Aluminium in Inflammatory and Glial Cells in Cerebral Amyloid Angiopathy: A Case Report.International journal of environmental research and public health · 2019
    Article
  14. EDTA Chelation Therapy for the Treatment of Neurotoxicity.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Matthew MoldThe Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire ST5 5BG, UK. m.j.mold@keele.ac.uk.ORCID 0000-0002-4616-6204
Agata ChmieleckaLife Sciences, The Huxley Building, Keele University, Staffordshire ST5 5BG, UK. aggychmi@gmail.com.
Maria Raquel Ramirez RodriguezThe Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire ST5 5BG, UK. raquel.ramirez3@hotmail.com.
Femia ThomLife Sciences, The Huxley Building, Keele University, Staffordshire ST5 5BG, UK. femiathom@hotmail.com.
Caroline LinhartDepartment of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, A-6020 Innsbruck, Austria. Linhart.Caroline@i-med.ac.at.
Andrew KingDepartment of Clinical Neuropathology, Kings College Hospital, London SE5 9RS, UK. andrewking@nhs.net.
Christopher ExleyThe Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire ST5 5BG, UK. c.exley@keele.ac.uk.ORCID 0000-0002-5116-7607
Keele University · GBInnsbruck Medical University · ATKing's College - North Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a devastating and debilitating neurodegenerative disease of unknown cause. A consensus suggests the involvement of both genetic and environmental factors of which the latter may involve human exposure to aluminium. There are no data on the content and distribution of aluminium in human brain tissue in MS. The aluminium content of brain tissue from 14 donors with a diagnosis of MS was determined by transversely heated graphite furnace atomic absorption spectrometry. The location of aluminium in the brain tissue of two donors was investigated by aluminium-specific fluorescence microscopy. The aluminium content of brain tissue in MS was universally high with many tissues bearing concentrations in excess of 10 μg/g dry wt. (10 ppm) and some exceeding 50 ppm. There were no statistically significant relationships between brain lobes, donor age or donor gender. Aluminium-specific fluorescence successfully identified aluminium in brain tissue in both intracellular and extracellular locations. The association of aluminium with corpora amylacea suggests a role for aluminium in neurodegeneration in MS.

Indexed as

Brain ChemistryAdultAgedAged, 80 and overAluminumFemaleHumansMaleMicroscopy, FluorescenceMiddle AgedMultiple SclerosisSpectrophotometry, AtomicAluminumaluminium-specific fluorescencehuman brain tissuehuman exposure to aluminiummultiple sclerosisTH GFAAS

Identifiers

PMID30126209
PMCPMC6121957
OpenAlexW2885886613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.